Skip to main content

Cardiomyopathy clinical trials at UCSF

17 in progress, 10 open to eligible people

Cardiomyopathy is a disease affecting the heart muscle. UCSF is running trials to test new treatments for heart conditions like hypertrophic cardiomyopathy and heart failure. One trial is studying the safety of TN-401, while another looks at the effectiveness of Aficamten. These studies help improve our understanding of heart disease.

Showing trials for

Last updated: